Sudden cardiac death after coronary artery bypass graft surgery and role of antiplatelet therapy.

ABSTRACT:

Background

While coronary artery bypass grafting (CABG) surgery is effective in reducing the risk of myocardial infarction and subsequent cardiac events by improving myocardial perfusion, the risk of sudden cardiac death (SCD) remains notable.

Methods

This retrospective observational study evaluated the efficacy of dual antiplatelet therapy (DAPT) in preventing sudden cardiac death (SCD) among patients undergoing CABG surgery at a major U.S. cardiac center (2012-2015). Data was manually extracted from electronic medical records between 23/04/2017 to 30/03/ 2018 and verified for accuracy, with patients categorized into DAPT or aspirin monotherapy groups based on discharge prescriptions.

Results

Of 2,476 patients followed in this post-CABG study, the analysis included 1

SUBMITTER: Ch IA 

PROVIDER: S-EPMC11856524 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature